NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Effects of a Three-Month Low Calorie Diet Weight Loss Intervention on Knee Replacement Outcomes

Not Applicable

Terminated

Conditions: Obesity

Interventions: Combination Product: LCD Intervention

First Posted Date: 2019-07-10

Last Posted Date: 2022-04-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 13

Registration Number: NCT04015011

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Device: Standard of Care MRI
Other: Fluciclovine PET scan added to MRI

First Posted Date: 2019-07-05

Last Posted Date: 2021-03-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 31

Registration Number: NCT04009083

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Active, not recruiting

Conditions: BRCA-Mutated Ovarian Carcinoma
BRIP1 Gene Mutation
EPCAM
MSH2 A636P
RAD51C Gene Mutation
MLH1 Gene Mutation
MSH6 Gene Mutation
PMS2 Gene Mutation

Interventions: Other: CASCADE genetic screening

First Posted Date: 2019-07-05

Last Posted Date: 2024-07-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 120

Registration Number: NCT04009148

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Ipilimumab
Drug: Nivolumab
Drug: Tocilizumab

First Posted Date: 2019-06-27

Last Posted Date: 2024-10-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 71

Registration Number: NCT03999749

Locations: 🇺🇸
The Angeles Clinic, Los Angeles, California, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
NYU Langone Health, New York, New York, United States

and more 1 locations

PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION

Completed

Conditions: Alzheimer Disease

Interventions: Diagnostic Test: Measure of OxPhos upregulation
Diagnostic Test: lactate (measured with 1H-MRSI)

First Posted Date: 2019-06-27

Last Posted Date: 2023-07-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 37

Registration Number: NCT03999879

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Withdrawn

Conditions: Schizophrenia

Interventions: Drug: NPA radiotracer
Drug: Raclopride radiotracer
Drug: Dextroamphetamine

First Posted Date: 2019-06-26

Last Posted Date: 2020-05-29

Lead Sponsor: NYU Langone Health

Registration Number: NCT03999190

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises

Not Applicable

Completed

Conditions: Lymphedema
Breast Cancer

Interventions: Behavioral: Kinect-TOLF Training System

First Posted Date: 2019-06-26

Last Posted Date: 2020-07-10

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT03999177

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Teachers Thriving Together

Not Applicable

Completed

Conditions: Social Emotional Competence

Interventions: Behavioral: ParentCorps FUNdamentals
Behavioral: Coaching
Behavioral: ParentCorps 101 E-learning
Behavioral: Training

First Posted Date: 2019-06-10

Last Posted Date: 2022-03-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 74

Registration Number: NCT03980834

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

Not Applicable

Active, not recruiting

Conditions: Ischemic Heart Disease

Interventions: Other: mHealth-CR

First Posted Date: 2019-06-06

Last Posted Date: 2024-03-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 400

Registration Number: NCT03978130

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
UMass Chan Medical School, Worcester, Massachusetts, United States

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Phase 2

Active, not recruiting

Conditions: Meningioma

Interventions: Drug: Lutathera

First Posted Date: 2019-06-03

Last Posted Date: 2024-06-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 32

Registration Number: NCT03971461

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy